Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 4/2011

01-12-2011 | Original Research

Chemopreventive Effects of Non-steroidal Anti-inflammatory Drugs in Early Neoplasm of Experimental Colorectal Cancer: an Apoptosome Study

Authors: Vivek Vaish, Lalita Tanwar, Jasmeet Kaur, Sankar Nath Sanyal

Published in: Journal of Gastrointestinal Cancer | Issue 4/2011

Login to get access

Abstract

Purpose

Apoptosis is a highly regulated mechanism of cell death where pro-apoptotic proteins and caspases play an important role. Activation of pro-caspases at a definite time is essential to control the whole caspase cascade. Mitochondrion contains some pro-apoptotic proteins, which need to come out in cytoplasm for apoptotic function such as Cytochrome c (Cyt c), while the Bcl-2 protein family works as the guard of mitochondrial membrane and prevents the escape of Cyt c. Once Cyt c is out in cytoplasm, it binds with Apaf-1 (another pro-apoptotic protein also essential for proper cell differentiation) and pro-caspase-9, forming the Apoptosome complex. In this study, the role of two non-steroidal anti-inflammatory drugs (NSAIDs), Diclofenac and Celecoxib, in experimentally induced early neoplasm of colon via apoptosome mechanism had been studied. It has been recognized that the prolonged use of NSAIDs has its effect on reducing the risk of colorectal cancer through apoptotic pathways. However, the role of NSAIDs in respect of apoptosome is not clear.

Methods

Western blotting and immunohistochemistry were performed, along with morphological and histological analysis.

Results

According to the expression levels of Cytochrome c, Apaf-1, Caspases, and Bcl-2, it was observed that NSAIDs do follow the mitochondrial or intrinsic pathway of apoptosis.

Conclusion

The effects of Diclofenac and Celecoxib on the expression of pro- and anti-apoptotic proteins have been observed, which may constitute the mechanism by which the NSAIDs are efficient in controlling the proliferation of neoplasm in the colon.
Literature
1.
go back to reference Sinicrope FA, Roddey G, McDonnell TJ, Shen Y, Cleary KR, Stephens LC. Increased apoptosis accompanies neoplastic development in the human colorectum. Clin Cancer Res. 1996;2:1999–2006.PubMed Sinicrope FA, Roddey G, McDonnell TJ, Shen Y, Cleary KR, Stephens LC. Increased apoptosis accompanies neoplastic development in the human colorectum. Clin Cancer Res. 1996;2:1999–2006.PubMed
3.
go back to reference Thun MJ, Henley SJ, Patron C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94:252–66.PubMed Thun MJ, Henley SJ, Patron C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94:252–66.PubMed
4.
go back to reference Hwang DH, Fung V, Dannenberg AJ. National cancer institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: Role of COX-dependent and -independent mechanisms. Neoplasia. 2002;4:91–7. doi:10.1038/sj/neo/7900226.PubMedCrossRef Hwang DH, Fung V, Dannenberg AJ. National cancer institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: Role of COX-dependent and -independent mechanisms. Neoplasia. 2002;4:91–7. doi:10.​1038/​sj/​neo/​7900226.PubMedCrossRef
5.
6.
go back to reference Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J. 1998;12:1063–73.PubMed Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J. 1998;12:1063–73.PubMed
8.
go back to reference Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS. Chemopreventive properties of a selective inducible Nitric Oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res. 2002;62:165–70.PubMed Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS. Chemopreventive properties of a selective inducible Nitric Oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res. 2002;62:165–70.PubMed
9.
go back to reference Kanwar SS, Vaipei K, Nehru B, Sanyal SN. Antioxidative effects of non-steroidal anti-inflammatory drugs during the initiation stages of experimental colon carcinogenesis in rat. J Environ Pathol Toxicol Oncol. 2008;27:89–100.PubMed Kanwar SS, Vaipei K, Nehru B, Sanyal SN. Antioxidative effects of non-steroidal anti-inflammatory drugs during the initiation stages of experimental colon carcinogenesis in rat. J Environ Pathol Toxicol Oncol. 2008;27:89–100.PubMed
10.
go back to reference Vaish V, Tanwar L, Sanyal SN (2010) The role of NF-kappaB and PPARgamma in experimentally induced colorectal cancer and chemoprevention by cyclooxygenase-2 inhibitors. Tumour Biol. 2010 Jun 1. [Epub ahead of print]. doi: 10.1007/s13277-010-0051-7. Vaish V, Tanwar L, Sanyal SN (2010) The role of NF-kappaB and PPARgamma in experimentally induced colorectal cancer and chemoprevention by cyclooxygenase-2 inhibitors. Tumour Biol. 2010 Jun 1. [Epub ahead of print]. doi: 10.​1007/​s13277-010-0051-7.
11.
go back to reference Hirose Y, Kuno T, Yamada Y, et al. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis. 2003;24:107–11.PubMedCrossRef Hirose Y, Kuno T, Yamada Y, et al. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis. 2003;24:107–11.PubMedCrossRef
12.
go back to reference Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.PubMedCrossRef Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.PubMedCrossRef
13.
go back to reference Ochiai M, Ushigome M, Fujiwara K, et al. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Am J Pathol. 2003;163:1607–14.PubMedCrossRef Ochiai M, Ushigome M, Fujiwara K, et al. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Am J Pathol. 2003;163:1607–14.PubMedCrossRef
14.
go back to reference Rodrigues MAM, Silva LAG, Salvadori DMF, de Camargo JLV, Montenegro MR. Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz J Med Biol Res. 2002;35:351–5.PubMed Rodrigues MAM, Silva LAG, Salvadori DMF, de Camargo JLV, Montenegro MR. Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz J Med Biol Res. 2002;35:351–5.PubMed
15.
go back to reference Marsden VS, O’Connor L, O’Reilly LA, et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature. 2002;419:634–7. doi:10.1038/nature01101.PubMedCrossRef Marsden VS, O’Connor L, O’Reilly LA, et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature. 2002;419:634–7. doi:10.​1038/​nature01101.PubMedCrossRef
19.
go back to reference Wang S, Yan NY, Cai R, Alimov I, Cohen D. Activation of mitochondrial pathway is crucial for tumor selective induction of apoptosis by LAQ824. Cell Cycle. 2006;5:1662–8.PubMedCrossRef Wang S, Yan NY, Cai R, Alimov I, Cohen D. Activation of mitochondrial pathway is crucial for tumor selective induction of apoptosis by LAQ824. Cell Cycle. 2006;5:1662–8.PubMedCrossRef
20.
go back to reference Zou H, Li Y, Liu X, Wang X. An Apaf-1·Cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 1999;274:11549–56.PubMedCrossRef Zou H, Li Y, Liu X, Wang X. An Apaf-1·Cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 1999;274:11549–56.PubMedCrossRef
22.
go back to reference Chu ZL, Pio F, Xie Z, Welsh K, Krajewska M, Krajewski S. A novel enhancer of the Apaf1 Apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J Biol Chem. 2001;276:9239–45. doi:10.1074/jbc.M006309200.PubMedCrossRef Chu ZL, Pio F, Xie Z, Welsh K, Krajewska M, Krajewski S. A novel enhancer of the Apaf1 Apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J Biol Chem. 2001;276:9239–45. doi:10.​1074/​jbc.​M006309200.PubMedCrossRef
23.
go back to reference Purring KC, McLendon G. Cytochrome c binding to Apaf-1: The effects of dATP and ionic strength. Proc Natl Acad Sci. 2000;97:11928–31.CrossRef Purring KC, McLendon G. Cytochrome c binding to Apaf-1: The effects of dATP and ionic strength. Proc Natl Acad Sci. 2000;97:11928–31.CrossRef
24.
go back to reference Johnson CE, Huang YY, Parrish AB, et al. Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues. Proc Natl Acad Sci. 2007;104:20820–5.PubMedCrossRef Johnson CE, Huang YY, Parrish AB, et al. Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues. Proc Natl Acad Sci. 2007;104:20820–5.PubMedCrossRef
25.
go back to reference Cecconi F, Gruss P. Apaf1 in developmental apoptosis and cancer: how many ways to die? Cell Mol Life Sci. 2001;58:1688–97.PubMedCrossRef Cecconi F, Gruss P. Apaf1 in developmental apoptosis and cancer: how many ways to die? Cell Mol Life Sci. 2001;58:1688–97.PubMedCrossRef
26.
go back to reference Saikumar P, Mikhailova M, Pandeswara SL. Regulation of caspase-9 activity by differential binding to the apoptosome complex. Front Biosci. 2007;12:3343–54.PubMedCrossRef Saikumar P, Mikhailova M, Pandeswara SL. Regulation of caspase-9 activity by differential binding to the apoptosome complex. Front Biosci. 2007;12:3343–54.PubMedCrossRef
27.
28.
go back to reference Hausmann G, O’Reilly LA, van Driel R, et al. Pro-apoptotic apoptosis protease–activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-xL. J Cell Biol. 2000;149:623–33.PubMedCrossRef Hausmann G, O’Reilly LA, van Driel R, et al. Pro-apoptotic apoptosis protease–activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-xL. J Cell Biol. 2000;149:623–33.PubMedCrossRef
29.
go back to reference Kim HE, Du F, Fang M, Wang X. Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci. 2005;102:17545–50.PubMedCrossRef Kim HE, Du F, Fang M, Wang X. Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci. 2005;102:17545–50.PubMedCrossRef
30.
go back to reference Bratton SB, Walker G, Srinivasula SM, Sun XM, et al. Recruitment, activation and retention of caspase-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J. 2001;20:998–1009.PubMedCrossRef Bratton SB, Walker G, Srinivasula SM, Sun XM, et al. Recruitment, activation and retention of caspase-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J. 2001;20:998–1009.PubMedCrossRef
31.
go back to reference Citterio S, Sgorbati S, Levi M, Colombo BM, Sparvoli E. PCNA and total nuclear protein content as markers of cell proliferation in pea tissue. J Cell Sci. 1992;102:71–8. Citterio S, Sgorbati S, Levi M, Colombo BM, Sparvoli E. PCNA and total nuclear protein content as markers of cell proliferation in pea tissue. J Cell Sci. 1992;102:71–8.
Metadata
Title
Chemopreventive Effects of Non-steroidal Anti-inflammatory Drugs in Early Neoplasm of Experimental Colorectal Cancer: an Apoptosome Study
Authors
Vivek Vaish
Lalita Tanwar
Jasmeet Kaur
Sankar Nath Sanyal
Publication date
01-12-2011
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 4/2011
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-010-9188-2

Other articles of this Issue 4/2011

Journal of Gastrointestinal Cancer 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.